Biomerica (BMRA)
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the det...
- Open
- 2.110
- High
- 2.150
- Low
- 1.940
- Prev. Close
- 2.090
- Volume
- 34.37K
- Turnover
- 70.86K
- Avg Price
- 2.062
- Bid/Ask Ratio
- 53.85%
- Amplitude
- 10.05%
- 52wk High
- 3.220
- Volume Ratio
- 6.32
- Turnover Ratio
- 1.24%
Biomerica Analyst Rating
View moreForecast & Rating
Feb 8, 2022Price forecast
$104.004876.08%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · 1 day ago, 09:05 PM
BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary
- PUBT · 1 day ago, 09:02 PM
Biomerica FY26 net sales drop 16% to $4.45 million; dividend, interest and other income more than doubled to $1.23 million
- TradingView · Aug 28 at 09:26 PM
BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake
- PUBT · Aug 27 at 09:24 PM
Biomerica CEO Zackary S. Irani reports acquisition of $50,000 common shares
- benzinga_article · Aug 27 at 03:56 PM
Biomerica shares are trading higher after the company announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the company’s common stock at a price of $1.60 per share.
- PUBT · Aug 26 at 08:57 PM
Biomerica prices 1,393,705-share private placement at $1.6 per share, raising $2.23 million
